UBS reiterates Buy on Ulta Beauty stock citing sustainable growth By Investing.com - ca.investing.com

UBS reiterated a Buy on Ulta Beauty with a $810 price target while the stock trades at $534.45 (market cap $23.3B). UBS's $810 PT reflects ~26x its 2027 EPS estimate of $31.40; InvestingPro consensus FY2027 EPS is lower at $28.35 after 20 analysts cut estimates. Other analysts are mixed — Evercore $675 PT, Argus cut to $615 from $700, Piper Sandler to $725 from $775 — signaling overall optimism offset by concerns about higher spending.

Analysis

Ulta’s optionality comes from a multi-channel moat that converts high-frequency purchase behavior into recurring revenue via loyalty and in-store services; if recent productivity initiatives continue to lift per-visit spend and salon utilization, the company can compound EPS at a mid-to-high single-digit rate while simultaneously funding growth. That creates a two-way lever: margin expansion from operational gearing and top-line resilience from loyalty cohorts, benefiting higher-margin proprietary brands and reducing working-capital volatility for upstream contract manufacturers.

Near-term risk centers on the cadence of investment versus payoff: an elongated spend cycle (marketing, store refreshes, salon rollouts) can force margin compression for multiple quarters, especially if promotional intensity rises in response to softer discretionary demand. Key catalysts to watch across weeks-to-months include gross-margin inflection, buy-online-pickup-in-store penetration, and salon revenue recovery — any one of which can materially shift consensus trajectories over a 3–12 month window.

Second-order effects: brands that over-index to Ulta’s assortments face lumpy order flows and inventory rebalancing if Ulta pares promotional cadence, which compresses supplier visibility and could raise wholesale discounting across the category. Competitive pressure from digitally native brands and Sephora’s strategic moves into value tiers will force Ulta to choose between protecting market share with higher short-term spend or protecting margins — that binary decision will drive the next re-rating.

Contrarian edge: consensus appears to be pricing a prolonged investment trough while underweighting operating-leverage potential once initiatives scale; conversely, the market has also not fully priced a scenario where incremental spend fails to produce comp lift and forces sustained margin cuts. The position to take should therefore express asymmetric upside to execution beats while limiting exposure to a multi-quarter execution miss.

Key Decisions for Investors

• Long ULTA equity, sized as a tactical overweight (6–8% of discretionary risk bucket). Enter on a relative weakness of 10–15% or on a confirmed sequential gross-margin improvement; target 40–60% upside over 12–24 months, stop-loss at -20% to protect against a multi-quarter investment-driven margin miss.
• Synthetic leveraged exposure via a 12–18 month call spread on ULTA: buy longer-dated ATM calls and sell higher OTM calls to fund ~60–80% of premium. Size to risk no more than 25% of a full-equity position; this yields 3:1+ payoff if execution drives re-rating while capping downside to the premium paid.
• Pair trade: long ULTA / short LVMUY (LVMH ADR) at a 1:0.6 dollar-neutral ratio over 6–12 months to express conviction in US specialty retail execution versus global luxury exposure. Target 20–30% relative outperformance; cut the pair if both names decline >25% on macro-led sell-off (hedge ratio adjustable to correlation changes).
• Event-driven tactical: buy near-term call spreads that expire 1–2 weeks after next quarterly results to capture upside from better-than-expected guidance or margin commentary. Risk is limited to premium; exit or reduce position immediately if management signals extended investment runway without clear KPIs or if comp guidance is trimmed.